Mark E. Drotar
- Aging top 10%
- Hematology top 10%
- Acute Myeloid Leukemia Research 2
- Chronic Myeloid Leukemia Treatments 2
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 2
-
- Immune Cell Function and Interaction 3
-
- Viral-associated cancers and disorders 4
-
- Lymphoma Diagnosis and Treatment 4
-
- Telomeres, Telomerase, and Senescence 2
-
- Genomics and Chromatin Dynamics 2
- Co-authors
- R. Armour ForsePeter BurkeJoanna B. WilsonPeter D. AdamsJohn van TuynTony McBryanPenelope M. TsimbouriWuning Zhong
- Cited by
- AgingHematologyGenetics
- Partner nations
- United KingdomUnited StatesSaudi Arabia
In The Last Decade
Mark E. Drotar
14 papers receiving 746 citations
Peers
Comparison fields: 5 of 73
- Aging 28
- Hematology 146
- Genetics 89
- Immunology 157
- Oncology 187
Countries citing papers authored by Mark E. Drotar
This map shows the geographic impact of Mark E. Drotar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Drotar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Drotar more than expected).
Fields of papers citing papers by Mark E. Drotar
This network shows the impact of papers produced by Mark E. Drotar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Drotar. The network helps show where Mark E. Drotar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark E. Drotar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2021 | 1 | |
| 3 | 2018 | 28 | |
| 4 | 2016 | 165 | |
| 5 | 2016 | 53 | |
| 6 | HIRA orchestrates a non-canonical dynamic chromatin landscape in senescence and is required for suppression of neoplasia | 2014 | 0 |
| 7 | 2013 | 251 | |
| 8 | 2013 | 47 | |
| 9 | 2008 | 7 | |
| 10 | 2003 | 26 | |
| 11 | 2003 | 5 | |
| 12 | 2002 | 48 | |
| 13 | Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages. | 1995 | 89 |
| 14 | Rapid modulation of liver-specific transcription factors after injury. | 1994 | 25 |
| 15 | 1993 | 1 |
About Mark E. Drotar
Mark E. Drotar is a scholar working on Hematology, Immunology, Pathology and Forensic Medicine, Physiology and Genetics, having authored 15 papers that have together received 753 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Immune Cell Function and Interaction (3 papers), Acute Myeloid Leukemia Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Telomeres, Telomerase, and Senescence (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Genomics and Chromatin Dynamics (2 papers). The work is most often cited by research in Aging (28 citations), Hematology (146 citations), Genetics (89 citations), Immunology (157 citations) and Oncology (187 citations). Mark E. Drotar has collaborated with scholars based in United Kingdom, United States and Saudi Arabia. Frequent co-authors include R. Armour Forse, Peter Burke, Joanna B. Wilson, Peter D. Adams, John van Tuyn, Tony McBryan, Penelope M. Tsimbouri, Wuning Zhong, S.R. Chavali and Greg Donahue. Their work appears in journals such as Oncogene, Blood, Nature Cell Biology, Journal of General Virology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.